Farchant, Germany

Robert Rauchenberger

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 5.9

ph-index = 9

Forward Citations = 222(Granted Patents)


Location History:

  • Martinsried/Planegg, DE (2013)
  • Martinsfried, DE (2016)
  • Farchant, DE (2009 - 2022)
  • Martinsried, DE (2013 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Robert Rauchenberger: Pioneering Innovations in Medical Antibodies

Introduction

Robert Rauchenberger, a prolific inventor based in Farchant, Germany, holds an impressive portfolio of 24 patents. His work primarily focuses on the development of innovative medical devices and antibody therapies aimed at treating various diseases, including cancer. Rauchenberger's cutting-edge inventions exemplify the marriage of science and technology in the pursuit of healthcare advancements.

Latest Patents

Among his latest contributions to the field are two significant patents. The first is for a medical device designed for administering anti-IL-23 antibodies. This invention encompasses a human anti-IL-23p19 antibody, alongside isolated nucleic acids encoding the antibody, as well as vectors and host cells, with applications in diagnostic and therapeutic compositions. The second patent involves anti-IGF antibodies, specifically fully human antibodies that bind to human IGF-1 and cross-react with IGF-2. This technology prevents the binding of IGF-1 and IGF-2 to the IGF-1 receptor, thereby inhibiting IGF-1 receptor-mediated signaling. These antibodies have potential applications in treating hyperproliferative diseases, particularly cancer, without affecting insulin’s mitogenic properties.

Career Highlights

Rauchenberger has made notable contributions to the pharmaceutical industry, having worked with notable companies such as Janssen Biotech, Inc. and MorphoSys AG. His expertise and innovative approach have consistently contributed to the advancement of therapeutic solutions in medicine.

Collaborations

Throughout his career, Rauchenberger has collaborated with esteemed professionals in the field, including Raymond W. Sweet and Mark Hilary Cunningham. These partnerships have played an essential role in fostering innovation and developing his groundbreaking technologies.

Conclusion

Robert Rauchenberger's dedication to innovation in the medical field has resulted in significant contributions that may impact the future of cancer treatment and other diseases. His extensive patent portfolio reflects his commitment to advancing science and technology, making him a notable figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…